Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.11 trillion and total revenue of $110.18 billion.
Market Cap
1.11T
Revenue
110.18B
Profits
-39.74B
PE Ratio
n/a
Profit Margin
-36.07%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.85B | -0.56% | 1,028,803 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.02B | -0.36% | 620,748 | 14.34B |
| 3 | ARGX | argenx SE | 46.67B | 2.30% | 361,784 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.38B | -3.28% | 1,305,075 | 3.71B |
| 5 | INSM | Insmed Incorporated | 35.19B | -0.48% | 1,350,372 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 33.69B | 0.44% | 194,566 | 5.34B |
| 7 | RPRX | Royalty Pharma plc | 27.04B | -0.95% | 2,626,477 | 2.38B |
| 8 | BNTX | BioNTech SE | 22.66B | -1.82% | 662,139 | 3.37B |
| 9 | MRNA | Moderna, Inc. | 19.87B | 2.75% | 4,300,898 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 19.86B | -0.47% | 3,273,779 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 19.08B | 0.98% | 1,033,721 | - |
| 12 | INCY | Incyte Corporation | 18.65B | -1.23% | 1,388,086 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.66B | -0.36% | 1,912,445 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 14.90B | 2.84% | 1,503,518 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.94B | -0.48% | 1,159,765 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 13.53B | -2.74% | 486,938 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.21B | -0.59% | 1,114,196 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.75B | 2.19% | 800,382 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.74B | -4.12% | 347,701 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.42B | 0.02% | 2,386,210 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.81B | 0.02% | 1,256,794 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.12B | -2.50% | 393,100 | 5.37M |
| 23 | PCVX | Vaxcyte, Inc. | 8.73B | 1.45% | 1,064,530 | - |
| 24 | AXSM | Axsome Therapeutics, Inc. | 8.63B | -0.59% | 401,331 | 638.50M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.57B | 0.10% | 1,180,490 | 1.09B |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 8.54B | -1.10% | 310,465 | 7.46M |
| 27 | TECH | Bio-Techne Corporation | 8.42B | 0.06% | 2,493,980 | 1.22B |
| 28 | CYTK | Cytokinetics, Incorporated | 8.06B | 0.83% | 1,327,526 | 88.04M |
| 29 | NUVL | Nuvalent, Inc. | 8.04B | -1.41% | 628,253 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 7.77B | 0.84% | 244,721 | 389.13M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.53B | 0.82% | 1,169,200 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 7.08B | -3.11% | 12,961,155 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.95B | -0.20% | 357,336 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.74B | 0.07% | 915,395 | 22.29M |
| 35 | BLTE | Belite Bio, Inc | 6.68B | -0.81% | 98,416 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.62B | 0.84% | 785,095 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.15B | -0.87% | 602,946 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.12B | -0.30% | 3,258,245 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.07B | -0.30% | 29,578,032 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.92B | -0.34% | 747,585 | 189.76M |
| 41 | CGON | CG Oncology, Inc. | 5.89B | 3.35% | 1,707,278 | 4.04M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.77B | -0.61% | 724,687 | 521.31M |
| 43 | PTCT | PTC Therapeutics, Inc. | 5.76B | 0.99% | 666,383 | 1.73B |
| 44 | COGT | Cogent Biosciences, Inc. | 5.74B | 0.56% | 2,590,985 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.73B | 2.23% | 1,031,811 | - |
| 46 | CELC | Celcuity Inc. | 5.59B | 1.17% | 608,715 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.50B | 1.43% | 667,498 | 7.50M |
| 48 | ERAS | Erasca, Inc. | 5.30B | -0.35% | 4,630,927 | - |
| 49 | CAI | Caris Life Sciences, Inc. | 5.30B | -1.37% | 1,508,986 | 812.03M |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | 0.17% | 4,299,426 | 1.00B |
| 51 | IMVT | Immunovant, Inc. | 5.01B | -1.12% | 1,350,456 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 4.93B | -0.89% | 1,432,729 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.77B | 1.12% | 1,319,079 | 3.51M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.56B | 0.82% | 349,202 | 2.04M |
| 55 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.14% | 1,846,715 | 634.21M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.43B | 2.06% | 1,090,930 | 761.41M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.09B | 0.73% | 164,459 | 268.09M |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.02B | 1.88% | 1,642,133 | 7.70M |
| 59 | SYRE | Spyre Therapeutics, Inc. | 4.02B | 4.53% | 799,899 | - |
| 60 | VKTX | Viking Therapeutics, Inc. | 3.91B | -0.68% | 1,489,520 | - |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.90B | -0.62% | 1,034,156 | 22.50M |
| 62 | GPCR | Structure Therapeutics Inc. | 3.87B | 5.62% | 961,272 | - |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.77B | -1.03% | 1,429,377 | 1.07B |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.49B | -1.01% | 663,979 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.33B | -3.69% | 1,373,326 | 1.03B |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.19B | 5.94% | 208,234 | 803.79M |
| 67 | DNLI | Denali Therapeutics Inc. | 3.08B | 0.15% | 1,196,899 | - |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.05B | 0.04% | 1,050,383 | 588.99M |
| 69 | ORKA | Oruka Therapeutics, Inc. | 3.00B | 7.50% | 1,415,754 | - |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.00B | -1.04% | 801,952 | - |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.93B | -2.04% | 336,224 | 451.36M |
| 72 | TVTX | Travere Therapeutics, Inc. | 2.92B | -0.50% | 987,679 | 490.73M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.89B | -1.63% | 774,972 | 376.07M |
| 74 | VERA | Vera Therapeutics, Inc. | 2.85B | -1.10% | 1,165,336 | - |
| 75 | ALMS | Alumis Inc. | 2.84B | 1.69% | 1,126,215 | 24.05M |
| 76 | TNGX | Tango Therapeutics, Inc. | 2.83B | -2.41% | 1,955,625 | 62.38M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.77B | -0.76% | 714,514 | 247.00M |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 2.71B | -4.42% | 1,439,006 | 218.71M |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.71B | 0.19% | 17,670,064 | 190.41M |
| 80 | ELVN | Enliven Therapeutics, Inc. | 2.58B | 10.84% | 3,055,442 | - |
| 81 | KOD | Kodiak Sciences Inc. | 2.58B | 7.15% | 1,554,820 | - |
| 82 | IRON | Disc Medicine, Inc. | 2.55B | 1.56% | 413,561 | - |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.46B | -0.06% | 633,166 | 1.55M |
| 84 | AAPG | Ascentage Pharma Group International | 2.44B | -0.29% | 2,540 | 82.08M |
| 85 | IMNM | Immunome, Inc. | 2.44B | 0.47% | 1,482,583 | 6.94M |
| 86 | BEAM | Beam Therapeutics Inc. | 2.43B | 1.07% | 1,896,105 | 139.74M |
| 87 | SRPT | Sarepta Therapeutics, Inc. | 2.42B | 1.23% | 1,882,505 | 2.20B |
| 88 | RLAY | Relay Therapeutics, Inc. | 2.41B | 8.27% | 5,421,640 | 15.36M |
| 89 | ZLAB | Zai Lab Limited | 2.37B | 2.44% | 472,461 | 460.16M |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.33B | 0.28% | 2,060,525 | - |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.27B | 1.22% | 1,477,844 | 673.00M |
| 92 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | - | 1,825,012 | 158.18M |
| 93 | ADMA | ADMA Biologics, Inc. | 2.21B | -0.22% | 3,433,755 | 510.17M |
| 94 | NKTR | Nektar Therapeutics | 2.19B | 2.03% | 483,934 | 55.23M |
| 95 | SNDX | Syndax Pharmaceuticals, Inc. | 2.17B | 1.44% | 825,745 | 172.35M |
| 96 | MANE | Veradermics, Incorporated | 2.12B | -11.14% | 357,006 | - |
| 97 | ADPT | Adaptive Biotechnologies Corporation | 2.11B | -2.63% | 1,405,270 | 276.98M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | -1.31% | 1,061,304 | 283.06M |
| 99 | AGIO | Agios Pharmaceuticals, Inc. | 2.06B | 0.89% | 1,483,592 | 54.03M |
| 100 | DFTX | Definium Therapeutics, Inc. | 2.05B | 0.73% | 1,351,717 | - |
| 101 | TYRA | Tyra Biosciences, Inc. | 2.03B | -3.08% | 841,701 | - |
| 102 | STOK | Stoke Therapeutics, Inc. | 2.00B | 3.02% | 461,037 | 184.42M |
| 103 | ZYME | Zymeworks Inc. | 1.92B | 0.62% | 455,357 | 105.97M |
| 104 | GLPG | Galapagos NV | 1.88B | -1.60% | 248,800 | 1.31B |
| 105 | CAPR | Capricor Therapeutics, Inc. | 1.84B | 0.92% | 713,722 | 11.13M |
| 106 | PHVS | Pharvaris N.V. | 1.82B | -2.01% | 149,199 | - |
| 107 | OCUL | Ocular Therapeutix, Inc. | 1.82B | 3.35% | 4,371,489 | 51.95M |
| 108 | ANAB | AnaptysBio, Inc. | 1.79B | -0.48% | 295,313 | 234.60M |
| 109 | MESO | Mesoblast Limited | 1.78B | -7.97% | 447,958 | 65.38M |
| 110 | INVA | Innoviva, Inc. | 1.72B | 1.13% | 530,352 | 411.33M |
| 111 | PVLA | Palvella Therapeutics, Inc. | 1.72B | 0.14% | 187,664 | - |
| 112 | VCEL | Vericel Corporation | 1.70B | -2.20% | 499,042 | 276.26M |
| 113 | NRIX | Nurix Therapeutics, Inc. | 1.69B | 3.55% | 1,741,688 | 83.98M |
| 114 | RXRX | Recursion Pharmaceuticals, Inc. | 1.68B | 1.27% | 10,451,796 | 74.68M |
| 115 | TRVI | Trevi Therapeutics, Inc. | 1.68B | 2.26% | 1,446,237 | - |
| 116 | SION | Sionna Therapeutics, Inc. | 1.65B | -1.66% | 373,547 | - |
| 117 | IMCR | Immunocore Holdings plc | 1.62B | 0.06% | 727,280 | 400.02M |
| 118 | RAPP | Rapport Therapeutics, Inc. | 1.60B | 3.43% | 349,853 | - |
| 119 | NTLA | Intellia Therapeutics, Inc. | 1.60B | 1.88% | 2,343,024 | 67.67M |
| 120 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | -0.32% | 537,498 | 868.45M |
| 121 | OCS | Oculis Holding AG | 1.56B | 0.23% | 173,627 | 1.51M |
| 122 | NUVB | Nuvation Bio Inc. | 1.55B | 1.35% | 2,842,794 | 62.90M |
| 123 | GENB | Generate Biomedicines, Inc. | 1.51B | -2.23% | 236,439 | 31.89M |
| 124 | DMRA | Damora Therapeutics, Inc. | 1.47B | -0.69% | 201,247 | - |
| 125 | VIR | Vir Biotechnology, Inc. | 1.47B | 1.21% | 1,413,313 | 68.56M |
| 126 | SVRA | Savara Inc. | 1.46B | 3.21% | 1,287,869 | - |
| 127 | ARDX | Ardelyx, Inc. | 1.46B | -0.34% | 1,803,545 | 407.32M |
| 128 | PGEN | Precigen, Inc. | 1.46B | -1.67% | 2,432,727 | 9.68M |
| 129 | NBTX | Nanobiotix S.A. | 1.44B | -8.00% | 53,763 | 38.27M |
| 130 | MBX | MBX Biosciences, Inc. | 1.43B | -3.55% | 1,225,204 | - |
| 131 | VRDN | Viridian Therapeutics, Inc. | 1.43B | 0.43% | 6,601,659 | 70.85M |
| 132 | MAZE | Maze Therapeutics, Inc. | 1.41B | -2.31% | 565,335 | 2.50M |
| 133 | BCAX | Bicara Therapeutics Inc. | 1.39B | 2.11% | 798,087 | - |
| 134 | BHVN | Biohaven Ltd. | 1.39B | 1.20% | 1,613,553 | - |
| 135 | ATAI | AtaiBeckley Inc. | 1.38B | -1.56% | 2,555,815 | 4.09M |
| 136 | IMTX | Immatics N.V. | 1.37B | -0.58% | 294,335 | 56.67M |
| 137 | GLUE | Monte Rosa Therapeutics, Inc. | 1.37B | 1.12% | 343,706 | 123.67M |
| 138 | IOVA | Iovance Biotherapeutics, Inc. | 1.37B | 0.61% | 9,693,015 | 263.50M |
| 139 | ZBIO | Zenas BioPharma, Inc. | 1.34B | 0.99% | 456,513 | 10.00M |
| 140 | WVE | Wave Life Sciences Ltd. | 1.34B | 0.14% | 2,707,214 | 42.73M |
| 141 | OLMA | Olema Pharmaceuticals, Inc. | 1.33B | 0.53% | 636,247 | - |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.31B | -1.72% | 1,406,410 | 9.77M |
| 143 | NVAX | Novavax, Inc. | 1.30B | 0.13% | 2,373,171 | 1.12B |
| 144 | MLTX | MoonLake Immunotherapeutics | 1.23B | 0.59% | 972,932 | - |
| 145 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | -2.45% | 777,087 | - |
| 146 | PHAR | Pharming Group N.V. | 1.15B | -0.48% | 11,454 | 376.13M |
| 147 | DBVT | DBV Technologies S.A. | 1.14B | 1.92% | 191,176 | 5.64M |
| 148 | EYPT | EyePoint, Inc. | 1.13B | 3.51% | 938,987 | 31.37M |
| 149 | SEPN | Septerna, Inc. | 1.12B | 0.24% | 189,550 | 45.95M |
| 150 | GERN | Geron Corporation | 1.11B | -0.57% | 17,088,277 | 183.88M |
| 151 | AVBP | ArriVent BioPharma, Inc. | 1.11B | 0.88% | 239,631 | - |
| 152 | QURE | uniQure N.V. | 1.07B | -1.44% | 1,092,228 | 16.10M |
| 153 | MPLT | MapLight Therapeutics, Inc. | 1.06B | 6.77% | 341,043 | - |
| 154 | KALV | KalVista Pharmaceuticals, Inc. | 1.03B | -0.35% | 1,256,369 | 73.62M |
| 155 | XERS | Xeris Biopharma Holdings, Inc. | 1.01B | -2.98% | 1,661,587 | 291.85M |
| 156 | IVA | Inventiva S.A. | 1.01B | -5.82% | 260,745 | 9.31M |
| 157 | ABCL | AbCellera Biologics Inc. | 1.00B | -2.65% | 3,959,241 | 75.13M |
| 158 | ANNX | Annexon, Inc. | 961.24M | 3.28% | 2,247,278 | - |
| 159 | CMPX | Compass Therapeutics, Inc. | 956.27M | -3.28% | 1,624,354 | 850.00K |
| 160 | CTMX | CytomX Therapeutics, Inc. | 929.56M | -2.27% | 6,266,945 | 76.20M |
| 161 | AKTS | Aktis Oncology, Inc. | 924.21M | 2.14% | 349,095 | 6.50M |
| 162 | VOR | Vor Biopharma Inc. | 913.03M | 3.56% | 2,341,620 | - |
| 163 | INBX | Inhibrx Biosciences, Inc. | 910.75M | -2.15% | 142,161 | 1.30M |
| 164 | GHRS | GH Research PLC | 910.59M | -3.04% | 74,985 | - |
| 165 | PHAT | Phathom Pharmaceuticals, Inc. | 910.12M | 2.67% | 838,745 | 175.11M |
| 166 | JANX | Janux Therapeutics, Inc. | 908.22M | -0.07% | 669,514 | 10.00M |
| 167 | XNCR | Xencor, Inc. | 902.80M | -1.05% | 489,902 | 125.58M |
| 168 | CGEM | Cullinan Therapeutics, Inc. | 899.42M | -0.40% | 462,326 | - |
| 169 | EVMN | Evommune, Inc. | 892.90M | 0.85% | 453,171 | 13.00M |
| 170 | ORIC | ORIC Pharmaceuticals, Inc. | 890.18M | -0.45% | 1,443,354 | - |
| 171 | FTRE | Fortrea Holdings Inc. | 889.19M | 5.55% | 1,026,363 | 2.72B |
| 172 | URGN | UroGen Pharma Ltd. | 877.74M | -3.12% | 506,920 | 109.79M |
| 173 | ABUS | Arbutus Biopharma Corporation | 871.83M | - | 841,131 | 14.08M |
| 174 | TBPH | Theravance Biopharma, Inc. | 852.72M | 2.86% | 422,641 | 107.46M |
| 175 | SANA | Sana Biotechnology, Inc. | 840.63M | -2.17% | 2,146,489 | - |
| 176 | SLS | SELLAS Life Sciences Group, Inc. | 809.92M | -0.44% | 3,213,383 | - |
| 177 | SPRY | ARS Pharmaceuticals, Inc. | 809.27M | -2.86% | 1,145,962 | 84.28M |
| 178 | JBIO | Jade Biosciences, Inc. | 806.81M | 1.18% | 601,789 | - |
| 179 | MNKD | MannKind Corporation | 791.82M | 0.39% | 3,022,264 | 348.97M |
| 180 | OMER | Omeros Corporation | 790.52M | 0.83% | 1,237,499 | - |
| 181 | KURA | Kura Oncology, Inc. | 779.07M | 3.89% | 1,455,053 | 67.48M |
| 182 | MGTX | MeiraGTx Holdings plc | 774.55M | -0.11% | 635,708 | 81.39M |
| 183 | SLDB | Solid Biosciences Inc. | 761.55M | - | 835,740 | - |
| 184 | DSGN | Design Therapeutics, Inc. | 753.64M | -2.47% | 364,644 | - |
| 185 | DRUG | Bright Minds Biosciences Inc. | 750.27M | 2.52% | 163,762 | - |
| 186 | MRVI | Maravai LifeSciences Holdings, Inc. | 742.92M | -2.03% | 2,054,145 | 185.74M |
| 187 | TENX | Tenax Therapeutics, Inc. | 733.88M | -1.95% | 289,846 | - |
| 188 | ARVN | Arvinas, Inc. | 727.24M | 1.34% | 917,641 | 262.60M |
| 189 | RLMD | Relmada Therapeutics, Inc. | 708.00M | -2.17% | 834,414 | - |
| 190 | SGP | SpyGlass Pharma, Inc. | 704.30M | -6.98% | 90,274 | - |
| 191 | ANRO | Alto Neuroscience, Inc. | 682.04M | -5.24% | 266,662 | - |
| 192 | LXRX | Lexicon Pharmaceuticals, Inc. | 677.89M | 0.63% | 1,888,215 | 49.80M |
| 193 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 672.28M | -5.72% | 380,115 | - |
| 194 | GYRE | Gyre Therapeutics, Inc. | 650.16M | - | 79,773 | 116.59M |
| 195 | REPL | Replimune Group, Inc. | 644.07M | -8.67% | 3,618,821 | - |
| 196 | LBRX | LB Pharmaceuticals Inc | 640.07M | -6.09% | 186,868 | - |
| 197 | ALLO | Allogene Therapeutics, Inc. | 638.70M | 0.77% | 3,897,843 | 22.00K |
| 198 | CBIO | Crescent Biopharma, Inc. | 638.04M | -0.88% | 264,950 | 10.84M |
| 199 | DRTS | Alpha Tau Medical Ltd. | 628.39M | 4.54% | 229,350 | - |
| 200 | PRME | Prime Medicine, Inc. | 603.84M | 2.10% | 1,346,881 | 4.63M |
| 201 | OCGN | Ocugen, Inc. | 587.94M | -1.69% | 4,926,299 | 4.41M |
| 202 | MDXG | MiMedx Group, Inc. | 573.47M | -0.52% | 811,847 | 418.63M |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 568.33M | -0.62% | 708,120 | 106.47M |
| 204 | CRMD | CorMedix Inc. | 566.79M | 1.27% | 896,943 | 311.71M |
| 205 | KYTX | Kyverna Therapeutics, Inc. | 564.05M | 3.90% | 672,999 | - |
| 206 | PRTA | Prothena Corporation plc | 557.71M | 3.19% | 481,342 | 9.68M |
| 207 | PROK | ProKidney Corp. | 552.51M | 1.10% | 951,561 | 893.00K |
| 208 | TECX | Tectonic Therapeutic, Inc. | 545.27M | -3.14% | 311,547 | - |
| 209 | ZURA | Zura Bio Limited | 536.08M | -6.77% | 440,792 | - |
| 210 | RIGL | Rigel Pharmaceuticals, Inc. | 530.73M | 5.01% | 471,740 | 294.28M |
| 211 | UPB | Upstream Bio, Inc. | 527.87M | -0.21% | 316,822 | 2.85M |
| 212 | LRMR | Larimar Therapeutics, Inc. | 523.57M | -0.20% | 1,087,690 | - |
| 213 | FDMT | 4D Molecular Therapeutics, Inc. | 522.77M | 3.02% | 1,051,240 | 85.21M |
| 214 | FULC | Fulcrum Therapeutics, Inc. | 521.48M | - | 905,867 | 80.00M |
| 215 | ACRS | Aclaris Therapeutics, Inc. | 521.23M | -1.32% | 1,094,927 | 7.83M |
| 216 | VALN | Valneva SE | 517.72M | -0.17% | 53,457 | 205.07M |
| 217 | AGMB | AgomAb Therapeutics NV | 512.22M | -10.17% | 185,839 | - |
| 218 | LYEL | Lyell Immunopharma, Inc. | 508.09M | 0.41% | 102,028 | 36.00K |
| 219 | TRDA | Entrada Therapeutics, Inc. | 498.60M | -0.22% | 155,630 | 25.42M |
| 220 | FBRX | Forte Biosciences, Inc. | 491.17M | -1.02% | 188,119 | - |
| 221 | ENGN | enGene Holdings Inc. | 491.03M | 1.24% | 357,784 | - |
| 222 | STTK | Shattuck Labs, Inc. | 485.21M | - | 433,346 | 1.00M |
| 223 | IMMX | Immix Biopharma, Inc. | 481.45M | 5.82% | 856,196 | - |
| 224 | VSTM | Verastem, Inc. | 478.70M | -0.55% | 1,152,770 | 30.91M |
| 225 | AVIR | Atea Pharmaceuticals, Inc. | 475.64M | 1.70% | 322,636 | - |
| 226 | EIKN | Eikon Therapeutics, Inc. | 475.34M | -6.99% | 335,353 | - |
| 227 | CTNM | Contineum Therapeutics, Inc. | 475.29M | -5.28% | 213,826 | - |
| 228 | VTVT | vTv Therapeutics Inc. | 474.66M | -3.26% | 92,295 | 17.00K |
| 229 | ADCT | ADC Therapeutics SA | 472.61M | 1.36% | 800,565 | 81.36M |
| 230 | LXEO | Lexeo Therapeutics, Inc. | 467.49M | 9.36% | 1,145,257 | - |
| 231 | YDES | YD Bio Limited | 462.00M | -7.76% | 11,331 | 510.36K |
| 232 | RGNX | REGENXBIO Inc. | 454.23M | - | 494,244 | 170.44M |
| 233 | ASMB | Assembly Biosciences, Inc. | 452.56M | -2.36% | 67,431 | 72.30M |
| 234 | ABSI | Absci Corporation | 446.82M | -1.35% | 3,822,190 | 2.80M |
| 235 | VNDA | Vanda Pharmaceuticals Inc. | 440.35M | 6.89% | 1,414,428 | 216.11M |
| 236 | ALT | Altimmune, Inc. | 439.76M | 1.50% | 2,039,568 | 41.00K |
| 237 | ARMP | Armata Pharmaceuticals, Inc. | 437.76M | 13.27% | 120,556 | 4.90M |
| 238 | EPRX | Eupraxia Pharmaceuticals Inc. | 437.01M | -4.65% | 140,697 | - |
| 239 | STRO | Sutro Biopharma, Inc. | 425.94M | 7.35% | 410,491 | 102.48M |
| 240 | AURA | Aura Biosciences, Inc. | 425.32M | -0.75% | 442,324 | - |
| 241 | XOMA | XOMA Royalty Corporation | 412.05M | 2.46% | 213,287 | 52.15M |
| 242 | IPSC | Century Therapeutics, Inc. | 406.17M | 3.20% | 1,574,233 | 109.16M |
| 243 | DNA | Ginkgo Bioworks Holdings, Inc. | 396.97M | -0.73% | 852,779 | 170.16M |
| 244 | NAUT | Nautilus Biotechnology, Inc. | 394.88M | -6.87% | 392,442 | - |
| 245 | ENTA | Enanta Pharmaceuticals, Inc. | 389.73M | 1.36% | 91,752 | 66.98M |
| 246 | NMRA | Neumora Therapeutics, Inc. | 387.75M | 0.47% | 1,301,846 | - |
| 247 | LCTX | Lineage Cell Therapeutics, Inc. | 378.61M | -1.30% | 1,039,458 | 14.56M |
| 248 | RCKT | Rocket Pharmaceuticals, Inc. | 377.82M | 0.58% | 2,275,173 | - |
| 249 | BNTC | Benitec Biopharma Inc. | 373.72M | -0.73% | 83,750 | - |
| 250 | PRTC | PureTech Health plc | 366.39M | 0.29% | 4,822 | 6.39M |
| 251 | IVVD | Invivyd, Inc. | 364.55M | -0.77% | 2,365,679 | 53.43M |
| 252 | PRLD | Prelude Therapeutics Incorporated | 363.15M | 19.57% | 689,637 | 12.14M |
| 253 | AVTX | Avalo Therapeutics, Inc. | 362.79M | -2.15% | 558,223 | 59.00K |
| 254 | CADL | Candel Therapeutics, Inc. | 362.57M | -1.39% | 1,224,892 | - |
| 255 | AUTL | Autolus Therapeutics plc | 361.95M | -2.16% | 985,498 | 75.39M |
| 256 | ANL | Adlai Nortye Ltd. | 361.62M | 8.89% | 503,229 | -1.35M |
| 257 | MNPR | Monopar Therapeutics Inc. | 358.77M | -0.13% | 161,476 | - |
| 258 | NAGE | Niagen Bioscience, Inc. | 358.71M | - | 485,847 | 129.42M |
| 259 | PBYI | Puma Biotechnology, Inc. | 354.61M | 1.16% | 307,007 | 228.37M |
| 260 | DMAC | DiaMedica Therapeutics Inc. | 352.93M | -1.06% | 199,565 | - |
| 261 | IRD | Opus Genetics, Inc. | 350.05M | 6.72% | 747,968 | 14.20M |
| 262 | RZLT | Rezolute, Inc. | 342.78M | 1.23% | 1,308,780 | - |
| 263 | CABA | Cabaletta Bio, Inc. | 341.76M | 1.99% | 1,842,303 | - |
| 264 | BCYC | Bicycle Therapeutics plc | 341.56M | 0.20% | 361,234 | 72.59M |
| 265 | XFOR | X4 Pharmaceuticals, Inc. | 339.13M | -8.35% | 686,955 | 35.11M |
| 266 | IMRX | Immuneering Corporation | 338.13M | -3.15% | 932,098 | - |
| 267 | OVID | Ovid Therapeutics Inc. | 337.60M | 11.30% | 6,244,243 | 7.25M |
| 268 | CLYM | Climb Bio, Inc. | 328.17M | 1.93% | 424,616 | - |
| 269 | NGNE | Neurogene Inc. | 325.66M | 2.15% | 70,454 | 925.00K |
| 270 | NGEN | NervGen Pharma Corp. | 321.30M | -9.57% | 716,924 | - |
| 271 | PALI | Palisade Bio, Inc. | 319.78M | -1.04% | 2,571,421 | - |
| 272 | GLSI | Greenwich LifeSciences, Inc. | 311.87M | 2.18% | 117,480 | - |
| 273 | ACIU | AC Immune SA | 308.52M | 15.19% | 610,616 | 4.51M |
| 274 | LENZ | LENZ Therapeutics, Inc. | 304.45M | 1.04% | 506,335 | 19.09M |
| 275 | IKT | Inhibikase Therapeutics, Inc. | 299.94M | -1.68% | 731,998 | 1.00 |
| 276 | SRZN | Surrozen, Inc. | 296.01M | -5.95% | 80,027 | 3.48M |
| 277 | ADAG | Adagene Inc. | 292.70M | 2.55% | 436,919 | 7.67M |
| 278 | FHTX | Foghorn Therapeutics Inc. | 291.74M | 1.84% | 75,116 | 30.91M |
| 279 | NBP | NovaBridge Biosciences | 285.92M | 2.48% | 434,978 | - |
| 280 | AVXL | Anavex Life Sciences Corp. | 285.43M | 4.05% | 1,072,865 | - |
| 281 | TARA | Protara Therapeutics, Inc. | 277.99M | 1.38% | 518,515 | - |
| 282 | ABEO | Abeona Therapeutics Inc. | 274.41M | 1.05% | 993,388 | 5.82M |
| 283 | ALEC | Alector, Inc. | 272.60M | 5.33% | 562,105 | 21.05M |
| 284 | EDIT | Editas Medicine, Inc. | 268.17M | 0.74% | 1,542,052 | 40.52M |
| 285 | CCCC | C4 Therapeutics, Inc. | 267.36M | -3.52% | 1,200,045 | 35.95M |
| 286 | SLN | Silence Therapeutics plc | 264.51M | -3.45% | 251,764 | 559.00K |
| 287 | SABS | SAB Biotherapeutics, Inc. | 264.24M | -2.34% | 186,115 | 114.70K |
| 288 | HELP | Cybin Inc. | 262.69M | -0.19% | 555,731 | - |
| 289 | CHRS | Coherus Oncology, Inc. | 250.32M | - | 735,077 | 42.17M |
| 290 | OBIO | Orchestra BioMed Holdings, Inc. | 249.30M | 0.47% | 107,141 | 33.48M |
| 291 | PLYX | Polaryx Therapeutics, Inc. | 244.29M | -9.95% | 272,798 | - |
| 292 | CLLS | Cellectis S.A. | 242.59M | -1.45% | 15,152 | 79.59M |
| 293 | ARCT | Arcturus Therapeutics Holdings Inc. | 241.88M | 3.53% | 405,338 | 82.03M |
| 294 | CAMP | Camp4 Therapeutics Corporation | 241.42M | 3.56% | 182,593 | 3.50M |
| 295 | KROS | Keros Therapeutics, Inc. | 241.34M | 3.12% | 314,777 | 244.06M |
| 296 | ALXO | ALX Oncology Holdings Inc. | 240.84M | -6.63% | 1,159,300 | - |
| 297 | CNTX | Context Therapeutics Inc. | 240.72M | -3.32% | 532,344 | - |
| 298 | SLGL | Sol-Gel Technologies Ltd. | 238.64M | -1.80% | 84,957 | 19.39M |
| 299 | VYGR | Voyager Therapeutics, Inc. | 236.01M | -0.25% | 576,481 | 40.37M |
| 300 | ELDN | Eledon Pharmaceuticals, Inc. | 231.70M | -1.29% | 1,196,763 | - |
| 301 | NERV | Minerva Neurosciences, Inc. | 224.16M | -0.96% | 157,408 | - |
| 302 | CGEN | Compugen Ltd. | 219.37M | 6.42% | 486,909 | 72.76M |
| 303 | OABI | OmniAb, Inc. | 218.62M | -1.95% | 372,746 | 18.67M |
| 304 | MDWD | MediWound Ltd. | 218.10M | 2.72% | 176,576 | 16.96M |
| 305 | FENC | Fennec Pharmaceuticals Inc. | 217.88M | -1.56% | 163,426 | 44.64M |
| 306 | MGNX | MacroGenics, Inc. | 212.91M | 5.35% | 1,334,682 | 149.50M |
| 307 | NVCT | Nuvectis Pharma, Inc. | 210.08M | 3.66% | 115,488 | - |
| 308 | KRRO | Korro Bio, Inc. | 200.62M | 0.87% | 176,256 | 6.39M |
| 309 | ENLV | Enlivex Ltd. | 197.83M | -4.60% | 182,038 | - |
| 310 | MIST | Milestone Pharmaceuticals Inc. | 197.47M | 5.92% | 3,146,799 | 1.55M |
| 311 | MENS | Jyong Biotech Ltd. | 194.56M | 2.43% | 89,759 | - |
| 312 | ABOS | Acumen Pharmaceuticals, Inc. | 189.92M | -4.71% | 759,408 | - |
| 313 | ZNTL | Zentalis Pharmaceuticals, Inc. | 189.39M | -0.74% | 344,506 | 26.87M |
| 314 | TNXP | Tonix Pharmaceuticals Holding Corp. | 185.66M | -3.97% | 311,472 | 13.11M |
| 315 | ELTX | Elicio Therapeutics, Inc. | 185.62M | -5.44% | 128,793 | - |
| 316 | CDXS | Codexis, Inc. | 179.92M | 4.76% | 1,951,358 | 70.39M |
| 317 | CRBU | Caribou Biosciences, Inc. | 179.75M | -4.62% | 1,006,541 | 11.16M |
| 318 | PRQR | ProQR Therapeutics N.V. | 179.11M | -6.08% | 647,433 | 19.19M |
| 319 | CNTN | Canton Strategic Holdings, Inc. | 177.33M | -3.69% | 430,868 | - |
| 320 | PLX | Protalix BioTherapeutics, Inc. | 176.45M | -0.90% | 452,187 | 52.74M |
| 321 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 172.22M | -4.24% | 252,193 | - |
| 322 | ACHV | Achieve Life Sciences, Inc. | 170.37M | -0.93% | 508,902 | - |
| 323 | UNCY | Unicycive Therapeutics, Inc. | 168.59M | 0.91% | 956,283 | - |
| 324 | RNAC | Cartesian Therapeutics, Inc. | 166.48M | 0.64% | 128,852 | 2.80M |
| 325 | SGMT | Sagimet Biosciences Inc. | 165.53M | -1.17% | 333,374 | - |
| 326 | ARTV | Artiva Biotherapeutics, Inc. | 164.86M | -8.50% | 129,883 | 251.00K |
| 327 | KPTI | Karyopharm Therapeutics Inc. | 162.54M | 14.08% | 1,037,327 | 146.07M |
| 328 | WHWK | Whitehawk Therapeutics, Inc. | 161.88M | -2.00% | 241,787 | 7.15M |
| 329 | DTIL | Precision BioSciences, Inc. | 161.53M | 4.16% | 272,374 | 34.26M |
| 330 | TLSA | Tiziana Life Sciences Ltd | 160.81M | -1.56% | 101,480 | - |
| 331 | NKTX | Nkarta, Inc. | 160.40M | -4.66% | 488,101 | - |
| 332 | CNTB | Connect Biopharma Holdings Limited | 159.39M | -1.40% | 625,239 | 64.00K |
| 333 | AGEN | Agenus Inc. | 155.90M | 7.69% | 1,844,098 | 114.20M |
| 334 | IMUX | Immunic, Inc. | 155.25M | 1.71% | 2,402,693 | - |
| 335 | SPRO | Spero Therapeutics, Inc. | 154.57M | 2.30% | 693,208 | 66.80M |
| 336 | KLRS | Kalaris Therapeutics, Inc. | 151.79M | 5.58% | 124,254 | - |
| 337 | ACOG | Alpha Cognition Inc. | 151.55M | 12.26% | 149,648 | 10.22M |
| 338 | HRTX | Heron Therapeutics, Inc. | 148.83M | -2.60% | 1,100,055 | 154.90M |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 144.87M | 1.15% | 2,883,920 | - |
| 340 | GALT | Galectin Therapeutics Inc. | 144.16M | -14.45% | 738,324 | - |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 142.37M | 2.33% | 90,752 | 2.00M |
| 342 | BDTX | Black Diamond Therapeutics, Inc. | 140.36M | -2.00% | 581,264 | 70.00M |
| 343 | MOLN | Molecular Partners AG | 140.32M | -4.21% | 5,328 | 856.30K |
| 344 | NTHI | NeOnc Technologies Holdings, Inc. | 138.55M | 1.39% | 63,710 | 39.99K |
| 345 | BMEA | Biomea Fusion, Inc. | 137.37M | 25.83% | 5,663,038 | - |
| 346 | HUMA | Humacyte, Inc. | 134.74M | -6.63% | 4,829,153 | 2.04M |
| 347 | FATE | Fate Therapeutics, Inc. | 133.70M | -3.36% | 1,373,409 | 6.65M |
| 348 | EQ | Equillium, Inc. | 121.39M | -4.48% | 485,021 | 4.39M |
| 349 | CBUS | Cibus, Inc. | 121.11M | -16.75% | 732,685 | 3.64M |
| 350 | IPHA | Innate Pharma S.A. | 119.73M | -2.88% | 40,521 | 10.57M |
| 351 | ANTX | AN2 Therapeutics, Inc. | 118.61M | -2.08% | 164,450 | - |
| 352 | GNLX | Genelux Corporation | 117.59M | -2.93% | 205,647 | 8.00K |
| 353 | PEPG | PepGen Inc. | 115.42M | -8.24% | 1,525,194 | - |
| 354 | KZIA | Kazia Therapeutics Limited | 109.93M | 31.06% | 413,681 | 1.27M |
| 355 | LONA | LeonaBio, Inc. | 109.72M | 6.28% | 41,460 | - |
| 356 | CRDF | Cardiff Oncology, Inc. | 106.65M | -1.27% | 921,547 | 593.00K |
| 357 | SGMO | Sangamo Therapeutics, Inc. | 106.10M | -8.08% | 7,427,540 | 39.55M |
| 358 | ONCY | Oncolytics Biotech Inc. | 104.52M | -5.26% | 831,146 | - |
| 359 | VRCA | Verrica Pharmaceuticals Inc. | 100.84M | -1.84% | 44,572 | 35.58M |
| 360 | TTRX | Turn Therapeutics Inc. | 98.94M | 0.90% | 31,125 | - |
| 361 | PMN | ProMIS Neurosciences, Inc. | 97.57M | -0.73% | 32,539 | - |
| 362 | SEER | Seer, Inc. | 95.35M | -1.17% | 70,206 | 16.58M |
| 363 | HURA | TuHURA Biosciences, Inc. | 93.78M | 1.72% | 1,241,560 | - |
| 364 | COYA | Coya Therapeutics, Inc. | 93.59M | -1.48% | 81,955 | 7.95M |
| 365 | PYXS | Pyxis Oncology, Inc. | 91.73M | 0.69% | 427,722 | 13.86M |
| 366 | ALDX | Aldeyra Therapeutics, Inc. | 91.48M | -1.30% | 1,303,556 | - |
| 367 | ANIX | Anixa Biosciences, Inc. | 90.19M | 3.86% | 106,687 | - |
| 368 | VANI | Vivani Medical, Inc. | 89.73M | -4.50% | 158,748 | - |
| 369 | AARD | Aardvark Therapeutics, Inc. | 88.14M | -2.18% | 140,577 | - |
| 370 | QTTB | Q32 Bio Inc. | 86.31M | 4.61% | 159,847 | 53.74M |
| 371 | INO | Inovio Pharmaceuticals, Inc. | 85.67M | -7.08% | 3,932,065 | 65.34K |
| 372 | SPRB | Spruce Biosciences, Inc. | 85.27M | -1.36% | 61,239 | 697.00K |
| 373 | CSBR | Champions Oncology, Inc. | 85.27M | 4.24% | 1,926 | 57.95M |
| 374 | EXOZ | eXoZymes, Inc. | 84.87M | -0.40% | 11,779 | -700.00 |
| 375 | MCRB | Seres Therapeutics, Inc. | 84.84M | 0.45% | 26,732 | 789.00K |
| 376 | OKYO | OKYO Pharma Limited | 83.97M | 1.91% | 96,032 | - |
| 377 | NRXS | NeurAxis, Inc. | 82.12M | -0.94% | 118,123 | 3.57M |
| 378 | RANI | Rani Therapeutics Holdings, Inc. | 81.53M | -1.51% | 612,722 | 1.63M |
| 379 | PLRX | Pliant Therapeutics, Inc. | 81.11M | - | 422,349 | - |
| 380 | FLNA | Filana Therapeutics, Inc. | 80.67M | -0.60% | 248,506 | - |
| 381 | PYPD | PolyPid Ltd. | 78.24M | -3.30% | 70,979 | - |
| 382 | GANX | Gain Therapeutics, Inc. | 78.15M | -0.54% | 687,688 | - |
| 383 | ATYR | aTyr Pharma, Inc. | 77.96M | -3.51% | 919,553 | 190.00K |
| 384 | GOSS | Gossamer Bio, Inc. | 77.38M | -4.68% | 8,479,403 | 48.47M |
| 385 | PTHS | Pelthos Therapeutics Inc. | 76.31M | -6.73% | 34,401 | 16.80M |
| 386 | FBIO | Fortress Biotech, Inc. | 75.68M | -6.37% | 1,614,023 | 63.26M |
| 387 | NRXP | NRx Pharmaceuticals, Inc. | 73.67M | -0.89% | 699,556 | 1.23M |
| 388 | ESLA | Estrella Immunopharma, Inc. | 73.38M | 26.47% | 1,232,661 | - |
| 389 | CGTX | Cognition Therapeutics, Inc. | 73.04M | -2.42% | 972,683 | - |
| 390 | IBIO | iBio, Inc. | 72.89M | 3.94% | 639,422 | 300.00K |
| 391 | MAIA | MAIA Biotechnology, Inc. | 72.81M | -6.98% | 909,523 | - |
| 392 | IBO | Impact BioMedical Inc. | 72.18M | 4.59% | 283,161 | 32.00K |
| 393 | GUTS | Fractyl Health, Inc. | 71.46M | -1.44% | 1,460,898 | 3.00K |
| 394 | BYSI | BeyondSpring Inc. | 70.73M | 0.58% | 12,186 | 1.88M |
| 395 | IFRX | InflaRx N.V. | 69.92M | 2.52% | 1,152,902 | 34.44K |
| 396 | MNOV | MediciNova, Inc. | 69.89M | 0.71% | 17,933 | 409.66K |
| 397 | XBIT | XBiotech Inc. | 69.82M | -1.29% | 24,496 | - |
| 398 | ACET | Adicet Bio, Inc. | 69.12M | -6.81% | 180,718 | - |
| 399 | CING | Cingulate Inc. | 69.07M | -4.19% | 291,386 | - |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 68.79M | -0.77% | 385,607 | - |
| 401 | DWTX | Dogwood Therapeutics, Inc. | 67.47M | -0.98% | 47,170 | - |
| 402 | COEP | Coeptis Therapeutics Holdings, Inc. | 65.09M | -10.52% | 108,218 | 1.36M |
| 403 | ANVS | Annovis Bio, Inc. | 64.37M | -3.40% | 647,952 | - |
| 404 | TCRX | TScan Therapeutics, Inc. | 60.88M | 2.88% | 1,548,558 | 10.33M |
| 405 | ATHE | Alterity Therapeutics Limited | 60.35M | 4.35% | 27,750 | 4.43M |
| 406 | ICCC | ImmuCell Corporation | 59.71M | -0.15% | 5,368 | 27.64M |
| 407 | OKUR | OnKure Therapeutics, Inc. | 58.66M | -1.38% | 115,409 | - |
| 408 | INKT | MiNK Therapeutics, Inc. | 57.60M | 1.40% | 39,260 | - |
| 409 | TIL | Instil Bio, Inc. | 57.31M | -0.12% | 46,076 | - |
| 410 | ACRV | Acrivon Therapeutics, Inc. | 56.95M | -6.37% | 590,126 | - |
| 411 | HYFT | MindWalk Holdings Corp. | 54.63M | -2.65% | 139,590 | 20.70M |
| 412 | ENTX | Entera Bio Ltd. | 54.55M | -1.68% | 65,722 | 42.00K |
| 413 | KZR | Kezar Life Sciences, Inc. | 54.48M | -0.14% | 40,454 | - |
| 414 | EDSA | Edesa Biotech, Inc. | 53.76M | 3.95% | 162,878 | - |
| 415 | IMA | ImageneBio, Inc. | 53.13M | 4.40% | 8,553 | 800.00K |
| 416 | MREO | Mereo BioPharma Group plc | 52.16M | 3.35% | 1,261,867 | 500.00K |
| 417 | OSTX | OS Therapies Incorporated | 51.71M | -3.15% | 1,393,238 | - |
| 418 | GRCE | Grace Therapeutics, Inc. | 51.53M | -18.18% | 5,635,617 | - |
| 419 | PDSB | PDS Biotechnology Corporation | 51.24M | 17.63% | 3,175,828 | - |
| 420 | ALGS | Aligos Therapeutics, Inc. | 51.24M | 2.35% | 48,642 | 2.19M |
| 421 | MGX | Metagenomi Therapeutics, Inc. | 51.16M | - | 132,178 | 25.21M |
| 422 | ACTU | Actuate Therapeutics, Inc. | 50.27M | 0.95% | 243,599 | - |
| 423 | RADX | Radiopharm Theranostics Limited | 49.17M | -1.58% | 148,791 | 10.86M |
| 424 | XLO | Xilio Therapeutics, Inc. | 49.15M | 0.47% | 30,688 | 43.77M |
| 425 | HOWL | Werewolf Therapeutics, Inc. | 48.60M | -3.85% | 605,913 | 1.14M |
| 426 | NTRB | Nutriband Inc. | 46.33M | 2.17% | 4,989 | 2.28M |
| 427 | TELO | Telomir Pharmaceuticals, Inc. | 45.38M | 1.54% | 44,274 | - |
| 428 | LSTA | Lisata Therapeutics, Inc. | 45.16M | - | 20,823 | 170.00K |
| 429 | IMMP | Immutep Limited | 44.98M | -1.25% | 457,446 | 5.28M |
| 430 | RNTX | Rein Therapeutics Inc. | 44.30M | 13.67% | 542,141 | - |
| 431 | RLYB | Rallybio Corporation | 42.58M | -0.86% | 146,264 | 858.00K |
| 432 | ATOS | Atossa Therapeutics, Inc. | 42.02M | -5.24% | 81,433 | - |
| 433 | LITS | Lite Strategy, Inc. | 41.09M | -0.88% | 75,844 | - |
| 434 | RNXT | RenovoRx, Inc. | 40.55M | -3.42% | 401,581 | 1.12M |
| 435 | SNSE | Sensei Biotherapeutics, Inc. | 40.46M | -9.56% | 52,521 | - |
| 436 | CELU | Celularity Inc. | 40.08M | -0.71% | 9,242 | 40.58M |
| 437 | VERU | Veru Inc. | 39.80M | 3.33% | 120,949 | 16.89M |
| 438 | NXTC | NextCure, Inc. | 39.63M | 0.91% | 55,396 | - |
| 439 | ATRA | Atara Biotherapeutics, Inc. | 38.52M | -3.29% | 29,975 | 120.77M |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 36.48M | 7.34% | 184,632 | 90.00K |
| 441 | ABVC | ABVC BioPharma, Inc. | 35.83M | 4.32% | 661,605 | 797.92K |
| 442 | CRVO | CervoMed Inc. | 35.55M | -3.52% | 34,908 | 4.01M |
| 443 | HYPD | Hyperion DeFi, Inc. | 34.97M | -6.97% | 241,881 | 813.46K |
| 444 | PTN | Palatin Technologies, Inc. | 34.38M | 5.38% | 25,313 | 8.96M |
| 445 | CVM | CEL-SCI Corporation | 34.23M | -2.08% | 155,691 | - |
| 446 | PLUR | Pluri Inc. | 34.13M | 4.15% | 2,008 | 1.34M |
| 447 | LGVN | Longeveron Inc. | 33.97M | 5.45% | 2,184,506 | 1.20M |
| 448 | INMB | INmune Bio Inc. | 33.76M | 3.25% | 399,892 | 50.00K |
| 449 | LIXT | Lixte Biotechnology Holdings, Inc. | 33.11M | -1.04% | 16,829 | - |
| 450 | DYAI | Dyadic International, Inc. | 32.05M | 1.66% | 6,781 | 3.09M |
| 451 | EVAX | Evaxion A/S | 31.69M | 2.01% | 13,581 | 7.53M |
| 452 | APLM | Apollomics, Inc. | 31.46M | 4.64% | 10,600 | 6.93M |
| 453 | BCTX | BriaCell Therapeutics Corp. | 31.41M | 2.55% | 131,797 | - |
| 454 | KYNB | Kyntra Bio, Inc. | 28.61M | 1.29% | 36,872 | 6.44M |
| 455 | NRSN | NeuroSense Therapeutics Ltd. | 26.87M | -0.26% | 119,825 | - |
| 456 | SNTI | Senti Biosciences, Inc. | 26.78M | -5.71% | 107,968 | 22.00K |
| 457 | TVRD | Tvardi Therapeutics, Inc. | 26.74M | -4.36% | 95,696 | - |
| 458 | PASG | Passage Bio, Inc. | 26.35M | -6.22% | 60,038 | - |
| 459 | IGC | IGC Pharma, Inc. | 25.92M | 0.90% | 114,522 | 1.11M |
| 460 | DARE | Daré Bioscience, Inc. | 25.77M | -2.21% | 75,282 | 1.03M |
| 461 | SER | Serina Therapeutics, Inc. | 25.61M | -3.26% | 132,927 | 130.00K |
| 462 | BOLD | Boundless Bio, Inc. | 25.54M | -3.39% | 33,043 | - |
| 463 | NEUP | Neuphoria Therapeutics Inc. | 24.80M | 6.48% | 132,358 | 14.99M |
| 464 | LEXX | Lexaria Bioscience Corp. | 24.64M | -6.60% | 389,271 | 522.00K |
| 465 | XCUR | Exicure, Inc. | 24.48M | -4.48% | 14,403 | 500.00K |
| 466 | AEON | AEON Biopharma, Inc. | 23.72M | 3.02% | 44,924 | - |
| 467 | SKYE | Skye Bioscience, Inc. | 23.57M | -1.18% | 112,940 | - |
| 468 | NNVC | NanoViricides, Inc. | 23.32M | 6.93% | 430,028 | - |
| 469 | MRKR | Marker Therapeutics, Inc. | 23.18M | -1.42% | 81,331 | 3.55M |
| 470 | TPST | Tempest Therapeutics, Inc. | 22.38M | -1.89% | 54,153 | - |
| 471 | OTLK | Outlook Therapeutics, Inc. | 22.28M | 6.18% | 8,808,024 | 205.70K |
| 472 | BRNS | Barinthus Biotherapeutics plc | 22.10M | -4.85% | 20,894 | 14.97M |
| 473 | CRIS | Curis, Inc. | 21.98M | 3.17% | 165,368 | 9.44M |
| 474 | VTGN | Vistagen Therapeutics, Inc. | 21.23M | -1.25% | 587,366 | 789.00K |
| 475 | TVGN | Tevogen Bio Holdings Inc. | 20.74M | 0.10% | 8,056 | - |
| 476 | QNTM | Quantum BioPharma Ltd. | 20.31M | 8.38% | 174,105 | - |
| 477 | COCP | Cocrystal Pharma, Inc. | 20.27M | -2.00% | 1,298,507 | - |
| 478 | PSTV | Plus Therapeutics, Inc. | 20.04M | -12.31% | 2,461,428 | 5.21M |
| 479 | KTTA | Pasithea Therapeutics Corp. | 19.90M | 0.62% | 152,710 | - |
| 480 | VYNE | VYNE Therapeutics Inc. | 19.76M | -1.77% | 47,541 | 570.00K |
| 481 | LTRN | Lantern Pharma Inc. | 19.73M | 8.64% | 296,138 | - |
| 482 | JSPR | Jasper Therapeutics, Inc. | 18.70M | -2.41% | 1,032,512 | - |
| 483 | CUE | Cue Biopharma, Inc. | 18.38M | 6.33% | 76,746,345 | 27.47M |
| 484 | ALLR | Allarity Therapeutics, Inc. | 18.35M | -1.69% | 66,888 | 320.00K |
| 485 | PLRZ | Polyrizon Ltd. | 17.97M | -9.92% | 37,460 | - |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 17.66M | -8.25% | 417,783 | 3.94M |
| 487 | ICU | SeaStar Medical Holding Corporation | 16.65M | -8.95% | 241,737 | 1.23M |
| 488 | GNTA | Genenta Science S.p.A. | 16.23M | 2.58% | 51,408 | - |
| 489 | HIND | Vyome Holdings, Inc. | 14.81M | -2.31% | 18,239 | 319.71K |
| 490 | CYCN | Cyclerion Therapeutics, Inc. | 14.71M | -16.14% | 1,157,465 | 2.07M |
| 491 | LPCN | Lipocine Inc. | 14.60M | 3.09% | 1,731,415 | 1.98M |
| 492 | PHIO | Phio Pharmaceuticals Corp. | 14.41M | -1.59% | 89,119 | - |
| 493 | INAB | IN8bio, Inc. | 14.08M | 1.42% | 20,836 | - |
| 494 | INTS | Intensity Therapeutics, Inc. | 13.34M | -4.37% | 37,007 | - |
| 495 | GTBP | GT Biopharma, Inc. | 13.04M | -7.12% | 489,704 | - |
| 496 | BCDA | BioCardia, Inc. | 13.02M | 0.85% | 22,680 | 3.00K |
| 497 | MBRX | Moleculin Biotech, Inc. | 12.86M | 3.88% | 68,582 | - |
| 498 | TRAW | Traws Pharma, Inc. | 12.79M | -6.98% | 83,000 | 2.85M |
| 499 | KAPA | Kairos Pharma, Ltd. | 12.70M | -4.32% | 18,533 | - |
| 500 | JUNS | Jupiter Neurosciences, Inc. | 12.70M | 2.64% | 123,833 | 21.80K |